Discover 2,147 paid clinical trials in Allentown, Pennsylvania. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 2,147
Comparing The Safety And Efficacy Of DEFENCATH® In Reducing Central-Line Bloodstream Infections (CLABSIs) In Adults Receiving Total Parenteral Nutrition Through A Central Venous Catheter (CVC)
for
Central Line Associated Blood Stream Infections (CLABSI)
Location: Philadelphia PA, New York NY, Baltimore MD,
Sponsor: CorMedix Therapeutics
Sex: All
Age: 18+
Code: NCT06822426
Phase3, Recruiting
BI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20)
Training for Urinary Leakage Improvement After Pregnancy
for
Urinary Incontinence, Delivery Complication
Location: Philadelphia PA, Providence RI, Durham NC, Chicago IL,
Sponsor: NICHD Pelvic Floor Disorders Network
Sex: Female
Age: 18+
Code: NCT06411158
Recruiting
Cooperative Huntington's Observational Research Trial
for
Huntington Disease
Location: Philadelphia PA, New York NY, Baltimore MD,
Sponsor: HP Therapeutics Foundation
Sex: All
Age: 0+
Code: NCT00313495
Recruiting
Antidepressant Adherence for Depressed Adults in Primary Care
for
Depression
Location: Philadelphia PA
Sponsor: University of Pennsylvania
Sex: All
Age: 21 - 64
Code: NCT06496646
Recruiting
Phase 1/2 Study of PYX-201 in Combination With Pembrolizumab in Advanced Solid Tumors
for
Advanced Solid Tumors
Location: Philadelphia PA, New York NY, Fairfax VA, Pittsburgh PA,
Sponsor: Pyxis Oncology, Inc
Sex: All
Age: 18+
Code: NCT06795412
Phase1, Phase2, Recruiting
Impact of Obicetrapib and Obicetrapib Plus Repatha on Lp(a) Levels
for
Dyslipidemias
Location: Philadelphia PA
Sponsor: NewAmsterdam Pharma
Sex: All
Age: 18 - 70+
Code: NCT06496243
Phase2, Recruiting
A Study of JNJ-90301900 in Combination With Chemoradiation Followed by Consolidation Immunotherapy for Non-Small Cell Lung Cancer (NSCLC)
for
Carcinoma, Non-Small-Cell Lung
Location: Philadelphia PA, New Brunswick NJ, New York NY,
Sponsor: Johnson & Johnson Enterprise Innovation Inc.
Sex: All
Age: 18+
Code: NCT06667908
Phase2, Recruiting
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
for
Crohn's Disease
Location: Philadelphia PA, Hershey PA, Hackensack NJ, New York NY,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 16 - 70+
Code: NCT06430801
Phase3, Recruiting
A Post-Approval Registry for Exablate 4000 Type 1.0 and Type 1.1 for Unilateral Pallidotomy for the Treatment of Advanced, Idiopathic Parkinson's Disease With Medication-refractory Moderate to Severe Motor Complications
for
Movement Disorders, Neurology, Parkinsons Disease
Location: Philadelphia PA, New York NY, Baltimore MD, Dallas TX
Sponsor: InSightec
Sex: All
Age: 30 - 70+
Code: NCT05539196
Recruiting
Physiological Effects of ANGPTL3 Variants in Humans
for
Hypocholesterolemia
Location: Philadelphia PA
Sponsor: University of Pennsylvania
Sex: All
Age: 18+
Code: NCT04234724
Recruiting
Surveillance vs. Endoscopic Therapy for Barrett's Esophagus With Low-grade Dysplasia
for
Barretts Esophagus With Dysplasia, Barrett Esophagus,
Location: Philadelphia PA, New York NY, Manhasset NY,